View in EDS HTML Full Text PDF Full Text

Real‐world data on efficacy/safety and economic impact of nivolumab administered every 2 and 4 weeks among Japanese patients.

Saved in:
Bibliographic Details
Title: Real‐world data on efficacy/safety and economic impact of nivolumab administered every 2 and 4 weeks among Japanese patients.
Authors: Tasaki, Yoshihiko1 (AUTHOR), Ito, Nanami1 (AUTHOR), Mimura, Yoshihisa1 (AUTHOR), Sugiyama, Yosuke1 (AUTHOR), Ogawa, Ryo2 (AUTHOR), Shimura, Takaya3 (AUTHOR), Nakamura, Motoki4 (AUTHOR), Kawakita, Daisuke5 (AUTHOR), Hamamoto, Shuzo6 (AUTHOR), Uemura, Takehiro7 (AUTHOR), Yokota, Keisuke8 (AUTHOR), Iida, Moeko1 (AUTHOR), Odagiri, Kunihiro1 (AUTHOR), Kimura, Yuka1 (AUTHOR), Hotta, Yuji1 (AUTHOR), Komatsu, Hirokazu9 (AUTHOR), Okuda, Katsuhiro8 (AUTHOR), Niimi, Akio7 (AUTHOR), Yasui, Takahiro6 (AUTHOR), Iwasaki, Shinichi5 (AUTHOR)
Source: Asia Pacific Journal of Clinical Oncology. Aug2024, Vol. 20 Issue 4, p515-521. 7p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17437555
DOI:10.1111/ajco.14073